Angela Cacace's most recent trade in Arvinas Inc was a trade of 2,583 Common Stock done at an average price of $7.5 . Disclosure was reported to the exchange on June 17, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Arvinas Inc | Angela Cacace | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 7.49 per share. | 17 Jun 2025 | 2,583 | 154,248 (0%) | 0% | 7.5 | 19,347 | Common Stock |
| Arvinas Inc | Angela Cacace | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2025 | 91,000 | 91,000 | - | - | Stock Option (right to buy) | |
| Arvinas Inc | Angela Cacace | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2025 | 59,600 | 156,831 (0%) | 0% | 0 | Common Stock | |
| Arvinas Inc | Angela Cacace | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 16.75 per share. | 24 Feb 2025 | 3,061 | 98,377 (0%) | 0% | 16.8 | 51,272 | Common Stock |
| Arvinas Inc | Angela Cacace | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 16.55 per share. | 24 Feb 2025 | 1,146 | 97,231 (0%) | 0% | 16.5 | 18,966 | Common Stock |
| Arvinas Inc | Angela Cacace | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 74,960 | 74,960 | - | - | Stock Option (right to buy) | |
| Arvinas Inc | Angela Cacace | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 49,092 | 100,944 (0%) | 0% | 0 | Common Stock | |
| Arvinas Inc | Angela Cacace | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2024 | 24,632 | 24,632 | - | - | Stock Option (right to buy) | |
| Arvinas Inc | Angela Cacace | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2024 | 15,995 | 51,852 (0%) | 0% | 0 | Common Stock |